8E3Y

Cryo-EM structure of the VPAC1R-PACAP27-Gs complex

Summary for 8E3Y

• Entry DOI: 10.2210/pdb8e3y/pdb
• EMDB information: 27873
• Descriptor: Guanine nucleotide-binding protein G(s) subunit alpha isoforms short, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, ... (7 entities in total)
• Functional Keywords: membrane protein, drug discovery, g protein coupled receptor, signalling
• Biological source: Homo sapiens (human); More
• Total number of polymer chains: 6
• Total formula weight: 163010.71

Authors

Piper, S.J.,Danev, R.,Sexton, P.,Wootten, D. (deposition date: 2022-08-17, release date: 2022-11-23, Last modification date: 2024-05-01)

Primary citation

Piper, S.J.,Deganutti, G.,Lu, J.,Zhao, P.,Liang, Y.L.,Lu, Y.,Fletcher, M.M.,Hossain, M.A.,Christopoulos, A.,Reynolds, C.A.,Danev, R.,Sexton, P.M.,Wootten, D.
Understanding VPAC receptor family peptide binding and selectivity.
Nat Commun, 13:7013-7013, 2022

PubMed Abstract: The vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) receptors are key regulators of neurological processes. Despite recent structural data, a comprehensive understanding of peptide binding and selectivity among different subfamily receptors is lacking. Here, we determine structures of active, Gs-coupled, VIP-VPAC1R, PACAP27-VPAC1R, and PACAP27-PAC1R complexes. Cryo-EM structural analyses and molecular dynamics simulations (MDSs) reveal fewer stable interactions between VPAC1R and VIP than for PACAP27, more extensive dynamics of VIP interaction with extracellular loop 3, and receptor-dependent differences in interactions of conserved N-terminal peptide residues with the receptor core. MD of VIP modelled into PAC1R predicts more transient VIP-PAC1R interactions in the receptor core, compared to VIP-VPAC1R, which may underlie the selectivity of VIP for VPAC1R over PAC1R. Collectively, our work improves molecular understanding of peptide engagement with the PAC1R and VPAC1R that may benefit the development of novel selective agonists.

PubMed: 36385145
DOI: 10.1038/s41467-022-34629-3

Experimental method

ELECTRON MICROSCOPY (2.3 Å)